PDL-1/PDL-2 blockade in mice dendritic cells by RNAi techniques to induce antitumor immunity. (Q38817335)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26599163%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

PDL-1/PDL-2 blockade in mice dendritic cells by RNAi techniques to induce antitumor immunity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26599163%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26599163%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Saeed Daneshmandi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26599163%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Ali Akbar Pourfathollah

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26599163%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Mohammad Hossein Karimi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26599163%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

1 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26599163%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26599163%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26599163%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26599163%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

1145-1158

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26599163%20AND%20SRC:MED&resulttype=core&format=json

Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity

1 March 2020

cites work

1 reference

Tumoricidal activity of human dendritic cells.

21 January 2018

1 reference

Trial watch: Dendritic cell-based interventions for cancer therapy

21 January 2018

1 reference

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

21 January 2018

1 reference

Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer

21 January 2018

1 reference

PD-1 and its ligands in tolerance and immunity

21 January 2018

1 reference

SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation

21 January 2018

1 reference

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

21 January 2018

1 reference

B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells

21 January 2018

1 reference

B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression

21 January 2018

1 reference

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

21 January 2018

1 reference

PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells

21 January 2018

1 reference

Regulation of T cell activation and tolerance by PDL2

21 January 2018

1 reference

Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice

21 January 2018

1 reference

PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells

21 January 2018

1 reference

PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions

21 January 2018

1 reference

Silencing IDO in dendritic cells: a novel approach to enhance cancer immunotherapy in a murine breast cancer model

21 January 2018

1 reference

The blockade of immune checkpoints in cancer immunotherapy

21 January 2018

1 reference

Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression.

21 January 2018

1 reference

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production

21 January 2018

1 reference

PD-L1 signal on liver dendritic cells is critical for Foxp3(+)CD4(+)CD25(+) Treg and liver tolerance induction in mice

21 January 2018

1 reference

Current status of interleukin-10 and regulatory T-cells in cancer

21 January 2018

1 reference

PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine

21 January 2018

1 reference

Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

Naturally occurring human IgM antibody that binds B7-DC and potentiates T cell stimulation by dendritic cells

21 January 2018

1 reference

Cross-linking the B7 family molecule B7-DC directly activates immune functions of dendritic cells.

21 January 2018

1 reference

Immunotherapeutic potential of B7-DC (PD-L2) cross-linking antibody in conferring antitumor immunity

21 January 2018

1 reference

siRNA knockdown of PD-L1 and PD-L2 in monocyte-derived dendritic cells only modestly improves proliferative responses to Gag by CD8(+) T cells from HIV-1-infected individuals

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/IMT.15.80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26599163%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference